Name: Apogee Therapeutics, Inc. (APGE) Cash Flow Statement
Creator: FinSpry

Apogee Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Apogee Therapeutics, Inc. (APGE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Operating Activities
Net Income	-182.15	-83.99	-43.40
Depreciation & Amortization	0.19	-3.07	0.00
Stock Based Compensation	23.33	6.10	2.14
Change in Working Capital	-2.00	6.38	9.82
Change in Accounts Payable	-1.07	1.61	0.42
Change in Other Working Capital	-0.93	0.09	11.40
Other Operating Activities	-10.55	5.83	11.40
Net Cash from Operating Activities	-171.17	-74.76	-16.43
Investing Activities
Capital Expenditures	-1.15	0.17	0.00
Purchases of Investments	-649.45	-303.74	0.00
Sales/Maturities of Investments	350.14	-273.74	0.00
Net Cash from Investing Activities	-300.46	-273.91	0.00
Financing Activities
Common Stock Issued	493.48	315.39	0.00
Other Financing Activities	1.63	0.00	-0.75
Net Cash from Financing Activities	495.11	315.39	168.32
Summary
Net Change in Cash	23.47	-33.28	151.89
Cash at Beginning of Period	118.61	151.89	0.00
Cash at End of Period	142.08	118.61	151.89
Free Cash Flow	-172.33	-74.97	-16.43